2008 ICD-9-CM Diagnosis 285.9 - Anemia unspecified

2008 ICD-9-CM Volume 1 Diagnosis Codes Home > Diseases Of The Blood And Blood-Forming Organs 280-289 > Other And Unspecified Anemias 285.* >
2008 ICD-9-CM Diagnosis 285.9
Anemia unspecified
On October 1, 2008 the 2009 ICD-9-CM codes came into effect. Therefore, this code may be out of date.
The 2009 version of ICD-9-CM 285.9 can be accessed here.
(a-NEE-mee-a) A condition in which the number of red blood cells is below normal.
A reduction in the number of circulating erythrocytes or in the quantity of hemoglobin.
A reduction in the number of red blood cells per cu mm, the amount of hemoglobin in 100 ml of blood, and the volume of packed red blood cells per 100 ml of blood. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability. --2004
285.9 is a specific code that can be used to specify a diagnosis
285.9 contains 30 index entries
View the ICD-9-CM Volume 1 285.* hierarchy
ICD9Data's sister site ProcedureCodes.com launches with the 2008/09 CPT® codes - read more on the ICD9Data.com blog.
285.9 also known as:
Anemia:
NOS
essential
normocytic, not due to blood loss
profound
progressive
secondary
Oligocythemia
285.9 excludes:

anemia (due to):
blood loss:
acute (285.1)
chronic or unspecified (280.0)
iron deficiency (280.0-280.9)

Index entries containing 285.9:
Anemia 285.9
with
disorder of
anaerobic glycolysis 282.3
pentose phosphate pathway 282.2
koilonychia 280.9
6-phosphogluconic dehydrogenase deficiency 282.2
achlorhydric 280.9
achrestic 281.8
Addison's (pernicious) 281.0
Addison-Biermer (pernicious) 281.0
agranulocytic 288.09
amino acid deficiency 281.4
aplastic 284.9
acquired (secondary) 284.81
congenital 284.01
constitutional 284.01
due to
chronic systemic disease 284.89
drugs 284.89
infection 284.89
radiation 284.89
idiopathic 284.9
myxedema 244.9
of or complicating pregnancy 648.2
red cell (acquired) (adult) (with thymoma) 284.81
congenital 284.01
pure 284.01
specified type NEC 284.89
toxic (paralytic) 284.89
aregenerative 284.9
congenital 284.01
asiderotic 280.9
atypical (primary) 285.9
autohemolysis of Selwyn and Dacie (type I) 282.2
autoimmune hemolytic 283.0
Baghdad Spring 282.2
Balantidium coli 007.0
Biermer's (pernicious) 281.0
blood loss (chronic) 280.0
acute 285.1
bothriocephalus 123.4
brickmakers' (see also Ancylostomiasis) 126.9
cerebral 437.8
childhood 282.9
chlorotic 280.9
chronica congenita aregenerativa 284.01
chronic simple 281.9
combined system disease NEC 281.0 [336.2]
due to dietary deficiency 281.1 [336.2]
complicating pregnancy or childbirth 648.2
congenital (following fetal blood loss) 776.5
aplastic 284.01
due to isoimmunization NEC 773.2
Heinz-body 282.7
hereditary hemolytic NEC 282.9
nonspherocytic
type I 282.2
type II 282.3
pernicious 281.0
spherocytic (see also Spherocytosis) 282.0
Cooley's (erythroblastic) 282.49
crescent - see Disease, sickle-cell
cytogenic 281.0
Dacie's (nonspherocytic)
type I 282.2
type II 282.3
Davidson's (refractory) 284.9
deficiency 281.9
2, 3 diphosphoglycurate mutase 282.3
2, 3 PG 282.3
6-PGD 282.2
6-phosphogluronic dehydrogenase 282.2
amino acid 281.4
combined B12 and folate 281.3
enzyme, drug-induced (hemolytic) 282.2
erythrocytic glutathione 282.2
folate 281.2
dietary 281.2
drug-induced 281.2
folic acid 281.2
dietary 281.2
drug-induced 281.2
G-6-PD 282.2
GGS-R 282.2
glucose-6-phosphate dehydrogenase (G-6-PD) 282.2
glucose-phosphate isomerase 282.3
glutathione peroxidase 282.2
glutathione reductase 282.2
glyceraldehyde phosphate dehydrogenase 282.3
GPI 282.3
G SH 282.2
hexokinase 282.3
iron (Fe) 280.9
specified NEC 280.8
nutritional 281.9
with
poor iron absorption 280.9
specified deficiency NEC 281.8
due to inadequate dietary iron intake 280.1
specified type NEC 281.8
of or complicating pregnancy 648.2
pentose phosphate pathway 282.2
PFK 282.3
phosphofructo-aldolase 282.3
phosphofructokinase 282.3
phosphoglycerate kinase 282.3
PK 282.3
protein 281.4
pyruvate kinase (PK) 282.3
TPI 282.3
triosephosphate isomerase 282.3
vitamin B12 NEC 281.1
dietary 281.1
pernicious 281.0
Diamond-Blackfan (congenital hypoplastic) 284.01
dibothriocephalus 123.4
dimorphic 281.9
diphasic 281.8
diphtheritic 032.89
Diphyllobothrium 123.4
drepanocytic (see also Disease, sickle-cell) 282.60
due to
blood loss (chronic) 280.0
acute 285.1
defect of Embden-Meyerhof pathway glycolysis 282.3
disorder of glutathione metabolism 282.2
fetal blood loss 776.5
fish tapeworm (D. latum) infestation 123.4
glutathione metabolism disorder 282.2
hemorrhage (chronic) 280.0
acute 285.1
hexose monophosphate (HMP) shunt deficiency 282.2
impaired absorption 280.9
loss of blood (chronic) 280.0
acute 285.1
myxedema 244.9
Necator americanus 126.1
prematurity 776.6
selective vitamin B12 malabsorption with proteinuria 281.1
Dyke-Young type (secondary)
(symptomatic) 283.9
dyserythropoietic (congenital) (types I, II, III) 285.8
dyshemopoietic (congenital) 285.8
Egypt (see also Ancylostomiasis) 126.9
elliptocytosis (see also Elliptocytosis) 282.1
enzyme deficiency, drug-induced 282.2
epidemic (see also Ancylostomiasis) 126.9
EPO resistant 285.21
erythroblastic
familial 282.49
fetus or newborn (see also Disease, hemolytic) 773.2
late 773.5
erythrocytic glutathione deficiency 282.2
erythropoietin-resistant (EPO resistant anemia) 285.21
essential 285.9
Faber's (achlorhydric anemia) 280.9
factitious (self-induced bloodletting) 280.0
familial erythroblastic (microcytic) 282.49
Fanconi's (congenital pancytopenia) 284.09
favism 282.2
fetal, following blood loss 776.5
fetus or newborn
due to
ABO
antibodies 773.1
incompatibility, maternal/fetal 773.1
isoimmunization 773.1
Rh
antibodies 773.0
incompatibility, maternal/fetal 773.0
isoimmunization 773.0
following fetal blood loss 776.5
fish tapeworm (D. latum) infestation 123.4
folate (folic acid) deficiency 281.2
dietary 281.2
drug-induced 281.2
folate malabsorption, congenital 281.2
folic acid deficiency 281.2
dietary 281.2
drug-induced 281.2
G-6-PD 282.2
general 285.9
glucose-6-phosphate dehydrogenase deficiency 282.2
glutathione-reductase deficiency 282.2
goat's milk 281.2
granulocytic 288.09
Heinz-body, congenital 282.7
hemoglobin deficiency 285.9
hemolytic 283.9
acquired 283.9
with hemoglobinuria NEC 283.2
autoimmune (cold type) (idiopathic) (primary) (secondary) (symptomatic) (warm type) 283.0
due to
cold reactive antibodies 283.0
drug exposure 283.0
warm reactive antibodies 283.0
fragmentation 283.19
idiopathic (chronic) 283.9
infectious 283.19
autoimmune 283.0
non-autoimmune 283.10
toxic 283.19
traumatic cardiac 283.19
acute 283.9
due to enzyme deficiency NEC 282.3
fetus or newborn (see also Disease, hemolytic) 773.2
late 773.5
Lederer's (acquired infectious hemolytic anemia) 283.19
autoimmune (acquired) 283.0
chronic 282.9
idiopathic 283.9
cold type (secondary) (symptomatic) 283.0
congenital (spherocytic) (see also Spherocytosis) 282.0
nonspherocytic - see Anemia, hemolytic, nonspherocytic, congenital
drug-induced 283.0
enzyme deficiency 282.2
due to
cardiac conditions 283.19
drugs 283.0
enzyme deficiency NEC 282.3
drug-induced 282.2
presence of shunt or other internal prosthetic device 283.19
thrombotic thrombocytopenic purpura 446.6
elliptocytotic (see also Elliptocytosis) 282.1
familial 282.9
hereditary 282.9
due to enzyme deficiency NEC 282.3
specified NEC 282.8
idiopathic (chronic) 283.9
infectious (acquired) 283.19
mechanical 283.19
microangiopathic 283.19
nonautoimmune 283.10
nonspherocytic
congenital or hereditary NEC 282.3
glucose-6-phosphate dehydrogenase deficiency 282.2
pyruvate kinase (PK) deficiency 282.3
type I 282.2
type II 282.3
type I 282.2
type II 282.3
of or complicating pregnancy 648.2
resulting from presence of shunt or other internal prosthetic device 283.19
secondary 283.19
autoimmune 283.0
sickle-cell - see Disease, sickle-cell
Stransky-Regala type (Hb-E) (see also Disease, hemoglobin) 282.7
symptomatic 283.19
autoimmune 283.0
acute 285.1
toxic (acquired) 283.19
uremic (adult) (child) 283.11
warm type (secondary) (symptomatic) 283.0
hemorrhagic (chronic) 280.0
HEMPAS 285.8
hereditary erythroblast multinuclearity-positive acidified serum test 285.8
Herrick's (hemoglobin S disease) 282.61
hexokinase deficiency 282.3
high A2 282.49
hookworm (see also Ancylostomiasis) 126.9
hypochromic (idiopathic) (microcytic) (normoblastic) 280.9
with iron loading 285.0
due to blood loss (chronic) 280.0
acute 285.1
familial sex linked 285.0
pyridoxine-responsive 285.0
hypoplasia, red blood cells 284.81
congenital or familial 284.01
hypoplastic (idiopathic) 284.9
congenital 284.01
familial 284.01
of childhood 284.09
idiopathic 285.9
hemolytic, chronic 283.9
in
chronic illness NEC 285.29
chronic kidney disease 285.21
end-stage renal disease 285.21
neoplastic disease 285.22
infantile 285.9
infective, infectional 285.9
intertropical (see also Ancylostomiasis) 126.9
iron (Fe) deficiency 280.9
due to blood loss (chronic) 280.0
acute 285.1
of or complicating pregnancy 648.2
specified NEC 280.8
Jaksch's (pseudoleukemia infantum) 285.8
Joseph-Diamond-Blackfan (congenital hypoplastic) 284.01
labyrinth 386.50
Lederer's (acquired infectious hemolytic anemia) 283.19
leptocytosis (hereditary) 282.49
leukoerythroblastic 284.2
macrocytic 281.9
nutritional 281.2
of or complicating pregnancy 648.2
tropical 281.2
malabsorption (familial), selective B12 with proteinuria 281.1
malarial (see also Malaria) 084.6
malignant (progressive) 281.0
malnutrition 281.9
marsh (see also Malaria) 084.6
Mediterranean (with hemoglobinopathy) 282.49
megaloblastic 281.9
combined B12 and folate deficiency 281.3
nutritional (of infancy) 281.2
of infancy 281.2
of or complicating pregnancy 648.2
refractory 281.3
specified NEC 281.3
megalocytic 281.9
microangiopathic hemolytic 283.19
microcytic (hypochromic) 280.9
due to blood loss (chronic) 280.0
acute 285.1
familial 282.49
hypochromic 280.9
microdrepanocytosis 282.49
miners' (see also Ancylostomiasis) 126.9
myelopathic 285.8
myelophthisic (normocytic) 284.2
newborn (see also Disease, hemolytic) 773.2
due to isoimmunization (see also Disease, hemolytic) 773.2
late, due to isoimmunization 773.5
posthemorrhagic 776.5
nonregenerative 284.9
nonspherocytic hemolytic - see Anemia, hemolytic, nonspherocytic
normocytic (infectional) (not due to blood loss) 285.9
due to blood loss (chronic) 280.0
acute 285.1
myelophthisic 284.2
nutritional (deficiency) 281.9
with
poor iron absorption 280.9
specified deficiency NEC 281.8
due to inadequate dietary iron intake 280.1
megaloblastic (of infancy) 281.2
of childhood 282.9
of chronic
disease NEC 285.29
illness NEC 285.29
of or complicating pregnancy 648.2
affecting fetus or newborn 760.8
of prematurity 776.6
orotic aciduric (congenital) (hereditary) 281.4
osteosclerotic 289.89
ovalocytosis (hereditary) (see also Elliptocytosis) 282.1
paludal (see also Malaria) 084.6
pentose phosphate pathway deficiency 282.2
pernicious (combined system disease) (congenital) (dorsolateral spinal degeneration) (juvenile) (myelopathy) (neuropathy) (posterior sclerosis) (primary) (progressive) (spleen) 281.0
of or complicating pregnancy 648.2
pleochromic 285.9
of sprue 281.8
portal 285.8
posthemorrhagic (chronic) 280.0
acute 285.1
newborn 776.5
postoperative
due to (acute) blood loss 285.1
chronic blood loss 280.0
other 285.9
postpartum 648.2
pressure 285.9
primary 285.9
profound 285.9
progressive 285.9
malignant 281.0
pernicious 281.0
protein-deficiency 281.4
pseudoleukemica infantum 285.8
puerperal 648.2
pure red cell 284.81
congenital 284.01
pyridoxine-responsive (hypochromic) 285.0
pyruvate kinase (PK) deficiency 282.3
refractoria sideroblastica 238.72
refractory (primary) 238.72
with
excess
blasts-1 (RAEB-1) 238.73
blasts-2 (RAEB-2) 238.73
hemochromatosis 238.72
ringed sideroblasts (RARS) 238.72
megaloblastic 281.3
sideroblastic 238.72
sideropenic 280.9
Rietti-Greppi-Micheli (thalassemia minor) 282.49
scorbutic 281.8
secondary (to) 285.9
blood loss (chronic) 280.0
acute 285.1
hemorrhage 280.0
acute 285.1
inadequate dietary iron intake 280.1
semiplastic 284.9
septic 285.9
sickle-cell (see also Disease, sickle-cell) 282.60
sideroachrestic 285.0
sideroblastic (acquired) (any type) (congenital) (drug-induced) (due to disease) (hereditary) (primary) (secondary) (sex-linked hypochromic) (vitamin B6 responsive) 285.0
refractory 238.72
sideropenic 280.9
due to blood loss (chronic) 280.0
acute 285.1
simple chronic 281.9
specified type NEC 285.8
spherocytic (hereditary) (see also Spherocytosis) 282.0
splenic 285.8
familial (Gaucher's) 272.7
splenomegalic 285.8
stomatocytosis 282.8
syphilitic 095.8
target cell (oval) 282.49
thalassemia 282.49
thrombocytopenic (see also Thrombocytopenia) 287.5
toxic 284.89
triosephosphate isomerase deficiency 282.3
tropical, macrocytic 281.2
tuberculous (see also Tuberculosis) 017.9
Vegan's 281.1
vitamin
B6-responsive 285.0
B12 deficiency (dietary) 281.1
pernicious 281.0
von Jaksch's (pseudoleukemia infantum) 285.8
Witts' (achlorhydric anemia) 280.9
Zuelzer (-Ogden) (nutritional megaloblastic anemia) 281.2
Deficiency, deficient
hemoglobin (see also Anemia) 285.9
Erythrocytopenia 285.9
Erythropenia 285.9
Findings, abnormal, without diagnosis (examination) (laboratory test) 796.4
hematocrit
low 285.9
hemoglobin
low 285.9
Hemoglobin - see also condition
low NEC 285.9
Hydremia 285.9
Impoverished blood 285.9
Low
hemoglobin 285.9
Normocytic anemia (infectional) 285.9
due to blood loss (chronic) 280.0
acute 285.1
Oligemia 285.9
Oligocythemia 285.9
Spanemia 285.9